For: | Li DQ, Wang ZB, Bai J, Zhao J, Wang Y, Hu K, Du YH. Reversal of multidrug resistance in drug-resistant human gastric cancer cell line SGC7901/VCR by antiprogestin drug mifepristone. World J Gastroenterol 2004; 10(12): 1722-1725 [PMID: 15188493 DOI: 10.3748/wjg.v10.i12.1722] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v10/i12/1722.htm |
Number | Citing Articles |
1 |
Monserrat Llaguno-Munive, Sebastián León-Zetina, Inés Vazquez-Lopez, María del Pilar Ramos-Godinez, Luis A. Medina, Patricia Garcia-Lopez. Mifepristone as a Potential Therapy to Reduce Angiogenesis and P-Glycoprotein Associated With Glioblastoma Resistance to Temozolomide. Frontiers in Oncology 2020; 10 doi: 10.3389/fonc.2020.581814
|
2 |
|
3 |
Kumi Kawano, Ayami Furuya, Yuri Matsuda, Chisato Kimura, Kotono Yamaguchi, Sakura Wakabayashi, Kotone Taniguchi, Kei-ichi Ozaki, Yoshiyuki Hattori. Preparation of liposomes co-encapsulating doxorubicin and mifepristone for treating multidrug-resistant cancer. Journal of Drug Delivery Science and Technology 2023; 85: 104605 doi: 10.1016/j.jddst.2023.104605
|
4 |
Sumit Jain, Vijay Rathod, Rameshwar Prajapati, Prajwal P. Nandekar, Abhay T. Sangamwar. Pregnane X Receptor and P-glycoprotein: a connexion for Alzheimer’s disease management. Molecular Diversity 2014; 18(4): 895 doi: 10.1007/s11030-014-9550-6
|
5 |
Jianzhong Chen, Jichuang Wang, Jingwei Shao, Yu Gao, Jianguo Xu, Suhong Yu, Zhenhua Liu, Lee Jia. The Unique Pharmacological Characteristics of Mifepristone (RU486): From Terminating Pregnancy to Preventing Cancer Metastasis. Medicinal Research Reviews 2014; 34(5): 979 doi: 10.1002/med.21311
|
6 |
Angelina Sampson, Brian G. Peterson, Kee W. Tan, Surtaj H. Iram. Doxorubicin as a fluorescent reporter identifies novel MRP1 (ABCC1) inhibitors missed by calcein-based high content screening of anticancer agents. Biomedicine & Pharmacotherapy 2019; 118: 109289 doi: 10.1016/j.biopha.2019.109289
|
7 |
Jose J.G. Marin, Rocio I.R. Macias, Elisa Herraez, Elisa Lozano, Marta R. Romero, Silvia Di Giacomo, Thomas Efferth, Oscar Briz. Drug Efflux Pumps in Cancer Resistance Pathways: From Molecular Recognition and Characterization to Possible Inhibition Strategies in Chemotherapy. 2020; : 197 doi: 10.1016/B978-0-12-816434-1.00007-3
|
8 |
Z. Dostál, P. Kosina, P. Mlejnek, K. Kikalová, M. Modrianský. Mifepristone potentiates etoposide toxicity in Hep G2 cells by modulating drug transport. Toxicology in Vitro 2019; 54: 33 doi: 10.1016/j.tiv.2018.09.005
|
9 |
Sven Marcel Stefan, Michael Wiese. Small‐molecule inhibitors of multidrug resistance‐associated protein 1 and related processes: A historic approach and recent advances. Medicinal Research Reviews 2019; 39(1): 176 doi: 10.1002/med.21510
|
10 |
Katja Silbermann, Sven Marcel Stefan, Randa Elshawadfy, Vigneshwaran Namasivayam, Michael Wiese. Identification of Thienopyrimidine Scaffold as an Inhibitor of the ABC Transport Protein ABCC1 (MRP1) and Related Transporters Using a Combined Virtual Screening Approach. Journal of Medicinal Chemistry 2019; 62(9): 4383 doi: 10.1021/acs.jmedchem.8b01821
|
11 |
Marina Leite, Raquel Seruca, Jorge M. Gonçalves. Hereditary Gastric and Breast Cancer Syndrome. 2023; : 281 doi: 10.1007/978-3-031-21317-5_20
|
12 |
Shuai Wang, Wujun Chen, Hualong Yu, Zhengming Song, Qian Li, Xin Shen, Yudong Wu, Lei Zhu, Qingxia Ma, Dongming Xing. lncRNA ROR Promotes Gastric Cancer Drug Resistance. Cancer Control 2020; 27(1): 107327482090469 doi: 10.1177/1073274820904694
|
13 |
Giulia Cossu, Marc Levivier, Roy Thomas Daniel, Mahmoud Messerer. The Role of Mifepristone in Meningiomas Management: A Systematic Review of the Literature. BioMed Research International 2015; 2015: 1 doi: 10.1155/2015/267831
|
14 |
Michael Wiese, Sven Marcel Stefan. The A‐B‐C of small‐molecule ABC transport protein modulators: From inhibition to activation—a case study of multidrug resistance‐associated protein 1 (ABCC1). Medicinal Research Reviews 2019; 39(6): 2031 doi: 10.1002/med.21573
|